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Aedes albopictus is known as a day biting mosquito and a vector of dengue 
viruses in Malaysia. One of the most effective prevention and control 
method for dengue currently in practice is the use of insecticides to control 
adult Aedes populations. Nonetheless, this Aedes species can develop 
resistance towards different types of insecticides and threaten vector 
control programs. In Subang Jaya, the escalating numbers of confirmed 
dengue cases in recent years suggest that the presence of resistance. Hence 
this study in the Subang Jaya Municipal area is intended to fill vital gaps 
in information on the extent of changes in its biological characteristics, 
development of resistance towards organophosphates and pyrethroids and 
the expression of metabolic genes. A total of 1,200 ovitraps were placed 
in 12 dengue outbreak and non outbreak known as hotspots (HS) and non-
hotspots (NHS) areas respectively. Analysis of biological characteristics 
revealed significant differences in fecundity, gonotrophic cycles, 
duration of immature stages and longevity in mosquito specimens in 
these two areas. HS Ae.albopictus specimens showed enhanced vectorial 
capacity as compared to NHS specimens. WHO adult bioassays using 4 
different types of insecticides against a total of 9,600 individual Aedes 
albopictus mosquitoes collected in HS and NHS areas indicated that the 
majority of local vector populations were already resistant to Malathion 
and Permethrin, yet susceptible to Deltamethrin and Lambdacyaluthrin. 
Analysis of gene expression, using 720 individual Ae.albopictus 
mosquitoes using qRT-PCR procedures, revealed that Ae.albopictus 
was capable of sequestering detoxification enzymes. Most HS 
mosquito specimen showed high positive amplification of Glutathione 
- S - Transferase (GST) and Cytochrome P450 (CytoP450). Similar 
findings were observed for NHS mosquitoes but gene expression was 
relatively low, indicating that vector populations were still susceptible 
towards existing insecticides. As for Esterase Lipase (EL) gene only 
the specimens collected from 2 localities demonstrated amplification, 
suggesting cross resistance. Risk ratio (RR) calculated for Mortality 
Rate (Mr) and Knockdown Rate (Kdr), suggested both HS and NHS 
specimens had equal risk of resistance (RR=1) towards Malathion. 
Resistance for Permethrin, Deltamethrin and Lambdacyaluthrin were 
found respectively, to be 1.2, 6.0 and 2.5 times higher among the HS 
specimens. Multivariate analysis employing 15 parameters, confirmed 
that there were significant differences of parameters tested in both HS 
and NHS specimens with Bonferroni adjusted p - value of a< 0.003. 
In conclusion, this study revealed significant differences in resistance 
status and underlying resistance attributes in Aedes albopictus obtained 
across Subang Jaya municipal areas. Therefore it appears that current 
mitigation measures, for managing dengue outbreaks using insecticides, 
may no longer be effective. 
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This study involved assessment of clinician's views on practicality, 
clinical efficacy and cost -effectiveness of PET-CT in oesophageal 
cancer management and decision making model-based economic 
evaluation to investigate the relative cost-effectiveness of PET/CT in 
oesophageal cancer management staging based on review of publications 
and retrospective data. Total of 73 clinicians included in the survey. 
Retrospective analysis of patient data from 2001-2008 taken from Royal 
Liverpool &Broadgreen University Hospital Trust (RLBUHT) medical 
records and North West Cancer Intelligence Services (NWCIS) database 
for the same period. A decision tree was developed using TREEAGE 
software. The relevant data on accuracy, sensitivity and specificity of 
each diagnostic test were linked in the model, to cost and the primary 
outcome measure, cost per quality-adjusted life-year (QALY). The model 
estimated the mean cost associated with each diagnostic procedure and 
assumed that patients entering the model were aged 35-75 years. The 
results of the cost-effectiveness analysis are presented in terms of the 
incremental cost-effectiveness ratios (ICERs).PET compared with 
conventional work-up results for ICER for the strategy estimated at 
£28,460 per QALY; PET/CT compared with PET for ICER was £ 32,590 
per QALY; and the ICER for PET/CT combined with conventional work-
up versus PET/CT was £ 44,118. The package become more expensive 
with each additional diagnostic test added to PET and the more effective 
in terms of QALYs gained. The conventional work-up is the preferred 
options as probabilistic sensitivity analysis shows at a willingness-
to-pay (WTP) threshold of £ 20,000 per QALY. Result of the current 
analysis suggests that the use of PET/CT in the diagnosis of oesophageal 
cancer is unlikely to be cost-effective given the current WTP thresholds 
that are accepted in the United Kingdom by decision-making bodies 
such as the National Institute for Health and Clinical Excellence and 
National Health Services. Based on the current model and given the 
limitations that are apparent in terms of limited availability of data, 
the modelling suggests that the most cost-effective diagnostic strategy 
are the conventional work-up given current data. Future studies need to 
secure robust cost data that can be verified from more than one source 
for the diagnostic tests involved. It is also crucial to have reliable and 
verifiable data on quality of life associated with this clinical condition. 
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